Similarly, CyH disrupts YAP-TEAD interaction and suppresses EMT and cancer stemness, making it another promising therapeutic agent for YAP/TAZ-driven cancers (Xiu et al., 2021[155]). The gene discussed is CMA1; the disease is cancer.